UNSPSC 51362204: Hexapropymate

This classification denotes a sedative and hypnotic with the molecular formula C10H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0J9RN2PRJ7, chemically known as cyclohexanol, 1-(2-propynyl)-, carbamate but generally known as hexapropymate, which bears US NIH Compound Identifier 9661. European Medicines Agency schedules Hexapropymate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08032MIG.

UNSPSC 51362204 Hexapropymate is a Commodity code that captures state and local procurement of pharmaceutical products and related health-supply systems. Recent solicitations under this code show state and local governments purchasing naloxone and drug deactivation systems for community health initiatives, generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing arrangements, and exploring direct-to-manufacturer prescription fulfillment models to manage pharmacy benefit costs. The issuing bodies span county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local government entities across multiple states including Minnesota and Oregon). Seminole County has emerged as a recent active buyer, procuring naloxone and drug deactivation systems through competitive bidding.

Geographic activity centers on Florida, Texas, and the Upper Midwest region. Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026 (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, requiring vendors to include all shipping and delivery costs in bids. The Minnesota Department of Administration's Office of State Procurement, administering the MMCAP cooperative purchasing alliance, issued an RFP (S1070000015802) posted January 20, 2026 with a March 26, 2026 response deadline to establish multiple contracts for generic multi-source pharmaceuticals and OTC products to be supplied through three authorized wholesalers (AmerisourceBergen, Cardinal Health, and Morris & Dickson), with awards effective July 1, 2026 and evaluation weighted 75 percent on price competitiveness. The Texas Health and Human Services Commission released an RFI (HHS0017013) on April 3, 2026 to gather market intelligence on direct-to-manufacturer prescription programs for potential future formal procurement. These opportunities reflect heightened state and local focus on pharmaceutical cost management, supply chain efficiency, and community health initiatives.